Trial Profile
Elucidation of Mechanisms Underlying Glucose-lowering Effect of Dulaglutide Using C13-acetate Breath Test and Its Anti-arteriosclerotic Effect Using Endothelial Function Test in Japanese Working T2DM Patients
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Apr 2017
Price :
$35
*
At a glance
- Drugs Dulaglutide (Primary) ; Insulin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 04 Apr 2017 New trial record